Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
hERG Channel Activity from US Patent US11912693: "Compounds for modulating S1P1 activity and methods of using the same"
Assay data:1 Active, 1 Activity ≤ 1 µM, 11 Tested
SummaryRelated BioAssays by Target
Experimental Evaluation of the In Vitro Inhibitory Effect (IC50) of hERG from US Patent US11912663: "Multi-targeted tyrosine kinase inhibitors and their pharmaceutical uses"
Assay data:15 Tested
Cross screening panel
Assay data:1 Tested
Safety47 Scan (DiscoverX - Eurofins)
Potassium Channel hERG Eurofins Panlabs panel
HERG_DOFETILIDE Eurofins SafetyScreen44 (BI)
Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method
Assay data:353 Active, 116 Activity ≤ 1 µM, 1804 Tested
Inhibition of human ERG
Assay data:1 Active, 1 Tested
Inhibition of hERG
Binding affinity to hERG (unknown origin)
Inhibition of human ERG at 3 uM relative to control
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Displacement of [3H]dofetilide from human ERG expressed in CHO-K1 cell membrane measured after 45 mins by topcount scintillation counting method
Assay data:12 Active, 12 Activity ≤ 1 µM, 12 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on